Literature DB >> 9510367

Erectile dysfunction in aging: upregulation of endothelial nitric oxide synthase.

C A Haas1, A D Seftel, K Razmjouei, M B Ganz, N Hampel, K Ferguson.   

Abstract

OBJECTIVES: To evaluate whether alterations in nitric oxide (NO) synthesis or activity contribute to age-related erectile dysfunction and to elucidate the mechanisms causing these alterations using the rabbit as our model of aging.
METHODS: We compared the ability of the rabbit cavernosal smooth muscle to relax in the organ bath in response to acetylcholine (Ach, endothelium-dependent vasodilator), sodium nitroprusside (SNP, an NO donor), and A23187 (a calcium ionophore) in young (6 month old) and aged (2.5 to 3.5 year old) rabbits. In addition, the immunohistochemical expression of endothelial nitric oxide synthase (eNOS) in both young and aged rabbit cavernosal tissue was examined. Endothelial integrity was examined immunohistochemically with JC70.
RESULTS: Ach-mediated relaxation of penile corporal tissue was significantly attenuated from a maximum of 68.39 +/- 6.27 (0.1 mM Ach, n = 4) in young rabbits to 39.02 +/- 4.88 (0.1 mM Ach, n = 6) in aged rabbits (P < 0.04). No statistically significant difference (P > 0.05) was noted between cavernosal relaxation to sodium nitroprusside between young rabbits (97.8%, 0.1 mM SNP, n = 5) and aged rabbits (76.1%, 0.1 mM SNP, n = 5). This suggested that the defect in the Ach-NO pathway was at the level of NO synthesis, not activity. Immunohistochemical staining for eNOS demonstrated upregulation in both the vascular endothelium and corporal smooth muscle of aged rabbit tissue compared with young rabbit cavernosal tissue (n = 5). Anatomic endothelial integrity was demonstrated in the young and aged rabbits by the presence of JC70. This suggested that the defect in the Ach-NO synthetic pathway was not at the level of eNOS and was not due to anatomic endothelial cell disruption. Finally, Ach-mediated cavernosal smooth muscle relaxation in the young rabbit was not significantly augmented (P > 0.05) in the presence of the calcium ionophore A23187 (10 microM). A23187, however, significantly augmented (P < 0.04) Ach-mediated relaxation in the aged rabbit from a maximum of 33.93 +/- 6.58 to 41.55 +/- 6.58 (10 microM Ach, n = 5). This suggested that a potential defect in the Ach-NO synthetic pathway was at the level of intracellular calcium flux and possibly at the level of the calcium-eNOS interaction.
CONCLUSIONS: Endothelium-dependent relaxation is attenuated in the aging rabbit; eNOS is upregulated in the aging rabbit; and no difference is noted in response to direct NO donation between the young and aged rabbit. The endothelium is anatomically intact in both the young and aging rabbit. The calcium ionophore A23187 augmented the attenuated vasorelaxation in the aging rabbit cavernosum (although not to the levels seen in the young rabbit cavernosum) and had no effect on the young rabbit cavernosum. These data suggest that erectile dysfunction in the aging rabbit cavernosum appears to be related to endothelial dysfunction and is characterized by eNOS upregulation and aberrant intracellular calcium fluxes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510367     DOI: 10.1016/s0090-4295(97)00715-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  eNOS-uncoupling in age-related erectile dysfunction.

Authors:  J M Johnson; T J Bivalacqua; G A Lagoda; A L Burnett; B Musicki
Journal:  Int J Impot Res       Date:  2011-02-03       Impact factor: 2.896

2.  Erectile function is improved in aged rats by PnTx2-6, a toxin from Phoneutria nigriventer spider venom.

Authors:  Kenia P Nunes; Haroldo A Toque; Marcia H Borges; Michael Richardson; R Clinton Webb; Maria Elena de Lima
Journal:  J Sex Med       Date:  2012-08-23       Impact factor: 3.802

Review 3.  Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.

Authors:  Stephen L Archer; Ferrante S Gragasin; Linda Webster; Derek Bochinski; Evangelos D Michelakis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Aging affects the association between endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction in the Korean male population.

Authors:  J E Park; W H Lee; T H Hwang; J A Chu; S Kim; Y H Choi; J S Kim; D K Kim; S H Lee; K P Hong; J D Seo; W R Lee
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

5.  The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway.

Authors:  Nirmala Devi Kanika; Moses Tar; Yuehong Tong; Dwaraka Srinivasa Rao Kuppam; Arnold Melman; Kelvin Paul Davies
Journal:  Am J Physiol Cell Physiol       Date:  2009-08-05       Impact factor: 4.249

6.  Calcium dobesilate potentiates endothelium-derived hyperpolarizing factor-mediated relaxation of human penile resistance arteries.

Authors:  Javier Angulo; Pedro Cuevas; Argentina Fernández; Sonia Gabancho; Sebastián Videla; Iñigo Sáenz de Tejada
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

7.  Activation and potentiation of the NO/cGMP pathway by NG-hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing.

Authors:  Javier Angulo; Pedro Cuevas; Argentina Fernández; Sonia Gabancho; Antonio Allona; Antonio Martín-Morales; Ignacio Moncada; Iñigo Sáenz de Tejada
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

Review 8.  The role of nitric oxide in erectile dysfunction: implications for medical therapy.

Authors:  Arthur L Burnett
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

9.  Effects of Schisandra chinensis fruit extract and gomisin A on the contractility of penile corpus cavernosum smooth muscle: a potential mechanism through the nitric oxide - cyclic guanosine monophosphate pathway.

Authors:  Bo Ram Choi; Hye Kyung Kim; Jong Kwan Park
Journal:  Nutr Res Pract       Date:  2018-06-04       Impact factor: 1.926

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.